2008 chpa annual report

AdvAncing chAnge 2008 Annual Repor t

Consumer Healthcare Products Association900 19th Street, NW, Suite 700 • Washington, DC 20006T 202.429.9260 F 202.223.6835

chpa-info.org

2

5

9

13

17

19

20

A message from CHPA’s president and chair

Treating kids and medicines with care

Fighting medicine abuse on all fronts

Shaping the future at home and around the world

Advocating for positive impact

Providing opportunities for future growth

CHPA staff officers

Contents


chpa-info.org

changeA d v A n c i n g

Relying on science and evidence, utilizing sound judgment, partnering with experts and

community leaders, CHPA has faced a number of challenges and opportunities over the last 12

months. The result is a stronger OTC and nutritional supplement industry. Led by the association’s

committed membership, the consumer healthcare products industry is changing and evolving

and stands ready to take on an even larger role in the healthcare of American consumers.

Working together for change

A d v A n c i n g c h A n g e

Merriam-Webster defines change as “to make different in

some particular … to make radically different … to give a

different position, course, or direction to.” Some changes

can have ripple effects, across broad expanses and into great

depths; sometimes the effects are transient and fade quickly

from the surface. Usually, time is the test.

The past 12 months have been marked by changes: some

great, some small, and some await the fullness of time to

determine their significance. One thing that has not

changed is the industry’s commitment to ensuring continued

access to safe and proven over-the-counter (OTC)

medications and nutritional supplements, the information

necessary for their appropriate use, and the fortitude to

always put consumers’ needs first.

It is CHPA’s commitment, not just to access to healthcare

products but to information on their use, that sets it apart.

Even by its own standard, the association reached new

heights in 2008. With the launch of OTCsafety.org, along

with efforts to ensure consumers have the latest information

on when and when not to administer oral cough and cold

medicines to children, strong programs to prevent medicine

abuse, and persistent advocacy for increased funding for

the U.S. Food and Drug Administration, CHPA has been

aggressive in charting a bold and progressive course for the

OTC medicine and nutritional supplement industries. And

through it all, CHPA has been led by its members, willingly

setting aside their competitive differences for the greater

good of the industry as a whole.

2008 AnnuAl RepoRt | 1

2 | ConsumeR HeAltHCARe pRoduCts AssoCiAtion

A message from chPA’s President And chAir

no publication could ever fully capture the unparalleled teamwork and exceptional level of cooperation that were demonstrated by chPA’s members. thanks to this incomparable solidarity, the association truly made a difference this past year.

John T. HendricksonCHPA Chair

Linda A. Suydam, D.P.A.CHPA President


This has been a year marked by remarkable

events. Olympic hopefuls representing

countries from around the globe converged

in Beijing, rewriting the record books

with their stunning accomplishments. An

unprecedented battle ensued during the U.S.

presidential primaries and general election

among candidates unique in American

politics in their experiences and personal

stories. Selfless volunteers traveled to faraway

lands to help strangers recover from disasters

and rebuild communities in traditionally

isolated Myanmar and China. These vastly

different individuals had disparate goals.

But the one common thread that binds

them together is that they all wanted to

make a difference and to change the status

quo. The same can be said for our industry.

Over the last 12 months, through CHPA,

the industry vigorously worked to address

issues in pioneering and thoughtful ways.

When FDA began its intense review of OTC

pediatric cough and cold medications,

the industry, recognizing the important

role these medicines play in the lives of

American families, quickly united and rose

to the occasion. CHPA member companies

implemented voluntary programs to bolster

the safe use of the products, developed a

multi-year research project to confirm the

correct dosages and reaffirm the efficacy of

the medicines, updated medicine labels, and

launched the largest consumer educational

campaign ever conducted by the association.

Teen medicine abuse was another issue that

demonstrates CHPA’s efforts to affect change. Although

drug abuse statistics among teens intentionally abusing

OTC cough medicines have remained static, CHPA

stepped up its activities and programs to not only

raise awareness about the issue but to provide

preventive tools to the individuals who have the power

to help stop the problem before it starts: parents and

other teen influencers.

Quality problems across a range of imported consumer

products raised serious and warranted concerns this

past year and took center stage not only for our industry

and others but for the nation as a whole. A longtime

champion of quality assurance, the association took it

on as its civic duty to work side-by-side with regulators

and legislators to help keep American consumers safe.

Because consumer safety is at the forefront of all that we

do, CHPA’s Educational Foundation, wholly supported

by the membership, developed OTCsafety.org. This new

online resource clearly demonstrates the industry’s

enduring commitment to ensuring that consumers

have easy access to timely information to help them

appropriately use and safely store all OTC medicines.

This Year in Review provides a comprehensive account

of these and some of the many other industry

accomplishments last year. But no publication could

ever fully capture the unparalleled teamwork and

exceptional level of cooperation that were demonstrated

by CHPA’s members time and time again. Thanks to this

incomparable solidarity, the association truly made a

difference this past year and will continue to do so in

the years to come.


changeM e t A l P l o W

An improvement over implements of the

past, the innovation of the metal plow tool

in about 3500 B.C. brought agriculture

a huge step forward, making systematic

planting over wide areas possible.




Treating kids And Medicines with care

American families rely on proven OTC medicines. OTCs offer

safe and effective treatments to help consumers feel better

and get back to their daily lives. Nowhere is this more true

than with medications to help parents when caring for their

children suffering from cough and cold symptoms.

Making sound decisions Based on Facts Pediatric OTC oral cough and cold medicines—medications available to American families for generations—have been the focus of high scrutiny over the past 12 months. Through it all, the OTC medicine industry has been actively involved with outside experts and the U.S. Food and Drug Administration to ensure the decision-making process is informed by the latest scientific data and information, and keeps American families’ needs and concerns in mind.

In its data-gathering effort preceding a scheduled meeting of FDA’s Nonprescription Drugs and Pediatric advisory committees in October 2007, CHPA asked Rocky Mountain Poison and Drug Center to scrutinize all the available data from the American Association of Poison Control Centers regarding pediatric oral cough and cold medications and to assess fatalities from all sources going back nearly 50 years. The data analysis underscored the rarity of adverse events associated with these medications. The data, however, uncovered three issues that sparked the medicine makers to act immediately.

• Whilerare,apatternofadverseeventsassociated with the misuse of these medicines among the very youngest of children surfaced.

• Inadditionandrelatedtomisuse,thedatauncovered adverse events associated with parents or caregivers administering multiple doses of certain antihistamines in an off-label effort to help their children sleep.

• Amongchildren,agestwothroughsix,unsupervised ingestion surfaced as a leading cause of adverse events.

Immediately, the nation’s medicine makers announced a voluntary withdrawal of infant cough and cold medicines to address the misuse of these medicines among children under the age of two. To ensure parents and caregivers had information, CHPA launched the OTCsafety.org web site; communicated broadly to the media and FDA; and reached out extensively to healthcare professional societies, retailers, and consumer groups. Educational materials

Treating kids And Medicines with carewere created to reinforce the message to parents that pediatric oral cough and cold medicines should not be used in children under the age of two. The association and its members also developed a strong scientific program to conduct the necessary studies to confirm the correct dosing for children over the age of two and to study the efficacy of these medications.

For generations, medical ethics held that testing medications on children should be avoided whenever possible. Additionally, the common cold and its symptoms present a number of other challenges for researchers. To confront these challenges, a CHPA expert group is developing new research tools for reevaluating the efficacy of OTC cough and cold products in children. This research effort will lead to the conduct of placebo-controlled efficacy trials in children in compliance with the most up-to-date clinical research standards. CHPA is working in close cooperation with experts from FDA and academia in the field of measuring subjective and objective symptoms. The association already has begun many of the pharmakokenetic studies.

In addition, CHPA urged FDA to accept new label language to tell parents not to use certain antihistamines to sedate their children.

To address unsupervised ingestions, CHPA reaffirmed its long commitment to reminding parents and other caregivers of the necessity of keeping medicines out of the reach and sight of children. The association went

even further, however. CHPA’s board of directors also committed to utilize child-resistant packages for all pediatric oral cough and cold medications and to include a dosing device with all liquid pediatric cough and cold medicines.

FDA convened its advisory committee in October 2007 to examine all aspects of the issue. At the meeting, CHPA and outside experts presented data demonstrating the long history of safety of pediatric oral cough and cold products when used appropriately, explaining industry’s voluntary withdrawal, and outlining its educational and science programs.

FDA has not made a decision on its advisory committees’ recommendation to-date. It did issue a public health advisory in January 2008 concurring with the industry’s voluntary withdrawal of infant oral cough and cold medicines. And in October 2008, the agency supported CHPA’s announcement that it was voluntarily updating pediatric oral cough and cold medicine labels. The updated labels, which are transitioning onto store shelves during the 2008/2009 cough and cold season, tell parents not to use them in children under age four and not to use certain antihistamines to sedate children.

All of these voluntary actions are part of the industry’s overall effort to address misuse and accidental ingestion in pediatric oral cough and cold medicines. A crucial part of these efforts involves a major public health education campaign seeking to change the rare behaviors that could lead to the misuse of and unsupervised ingestions with pediatric oral cough and cold medicines. In concert with healthcare professionals and other expert and consumer groups, the industry has developed educational materials, advertising, public service announcements, and point of sale information to ensure parents and caregivers have the information they need when they need it.

leading the Way on otc safetyMuch has changed during the past 12 months, but the industry’s dedication to providing consumers with relevant information to safely use and store all OTC medicines is unremitting. In October 2007,

the scientific program proposed and begun by chPA and its members is a first-of-its-kind for pediatric otc cough and cold medicines in the world.


CHPA’s Educational Foundation introduced OTCsafety.org to provide information specifically on pediatric oral cough and cold medicines. The web site expanded in January 2008 and became the new home of all of the foundation’s educational initiatives concerning OTC medicines, for both the safe use of medicines and for sound prevention efforts combating the abuse of medicines.

OTCsafety.org provides educational brochures and resources for consumers to download or order at no cost. The site is constantly growing its database of subscribers through the “get involved” feature on the web site and by collecting new names through continued outreach and exhibiting. The CHPA Educational Foundation also is exploring additional interactive features that will further enhance the OTCsafety.org site experience in the upcoming year.

In 2007, FDA received a citizen’s petition asking the agency to look at pediatric oral cough and cold medicines, which have been recognized as safe and effective monographed medications for generations. CHPA is actively engaged in the process.

o c t o B e r 2 0 0 7 : - Rocky Mountain Poison and Drug Center and internal data analyses for

CHPA illustrates rare cases of serious adverse events from pediatric oral cough and cold medications are generally associated with misuse or accidental ingestion.

- Based on the poison control data analysis, CHPA members voluntarily withdraw infant oral cough and cold medicines to help prevent rare cases of misuse of these medicines in very young children.

- CHPA creates and launches OTCsafety.org to inform parents about the voluntary withdrawal and provide safe use tips.

- FDA hosts a meeting of its Nonprescription Drugs and Pediatric advisory committees.

n o v e M B e r 2 0 0 7 :- CHPA commits to going beyond current regulations by making all

pediatric oral cough and cold medicine packages comply with child-resistant technologies to help address adverse events associated with unsupervised ingestion.

J A n u A r y 2 0 0 8 : - FDA issues a public health advisory lauding industry’s voluntary

withdrawal of infant cough and cold medicines and echoing industry’s call to parents not to use these medications for children under the age of two.

- CHPA relaunches its educational foundation under the OTCsafety.org web site.

A P r i l 2 0 0 8 : - U.S. Centers for Disease Control and Prevention researchers publish an

article in the journal Pediatrics highlighting that two-thirds of emergency-room visits associated with pediatric cough and cold medicines among children under the age of six are due to unsupervised ingestion.

A u g u s t 2 0 0 8 : - FDA announces an upcoming public meeting to gather more information

on pediatric cough and cold medicines.

o c t o B e r 2 0 0 8 : - FDA convenes its public meeting.

- CHPA announces voluntary label updates following consultations with FDA.



changeP r i n t i n g P r e s s

Gutenberg’s printing press with movable type was

an improvement over handwritten manuscripts

and block printing and led to the complete

transformation of the fabric of the social order in

the Western world. Within decades of the press’s

development in 1454, adult literacy and ideas

spread to segments of the population never before

touched by them, and vernacular languages become

dominant over canonical Latin.




Teens intentionally abusing good medicines is not only

bad behavior, it is dangerous. CHPA members remain

unified in their position that this destructive behavior must

end. That is why the association developed and implemented

a number of programs aimed at stopping the abuse of cough

medicine through various networks. All of these programs

are linked through the one site, StopMedicineAbuse.org.

This portal site provides quick access to all of CHPA’s

educational materials, programs, and campaigns focused on

fighting teen medicine abuse.

CHPA’s efforts to combat teen medicine abuse follow the

same course as all of the association’s initiatives. Grounded

in data, with input from members and outside experts

and alongside partners in the community, and incorporating

legislative initiatives that advance the cause, CHPA’s

messaging and programming demonstrate the best practices

for affecting behavioral change.

empowering Parents to help other ParentsOne of CHPA’s most successful educational initiatives, the Five Moms: Stopping Cough Medicine Abuse Campaign, uses five real-life mothers who are dedicated to raising awareness about the dangers of teen OTC cough medicine abuse. The most wide-reaching instrument of the campaign is its web site, FiveMoms.com, which educates parents about the problem and arms them with information on how to stop it. Celebrating its one-year anniversary in May 2008, CHPA transformed FiveMoms.com from a blog site to a more feature-based content site. In July 2008, FiveMoms.com was reintroduced with a new Spanish-language section, as well as information focused on teaching parents how to communicate with their kids and what steps they can take to keep teens from abusing medicines. In addition to changes to its web site, the campaign is continuing its Five Moms community on Gather.com to encourage open dialogue and information sharing.

Fighting Medicine ABuse on all fronts

Five Moms was involved in several other activities last year including providing subscribers with a new monthly e-newsletter. The campaign also held a Five Moms All-Stars Contest from January to May 2008, which honored one person each month for making a difference in her community by utilizing Five Moms content or tools. In addition, the campaign gained exposure by participating in town hall meetings in Kansas and Texas and conferences where influential message multipliers convene, like BlogHer 2008, held in July in San Francisco.

Building locallyCHPA and the Community Anti-Drug Coalitions of America’s (CADCA’s) Dose of Prevention Campaign is now in its second year of sending messages of cough medicine abuse awareness and prevention into local communities. Educational toolkits are available to coalition leaders, retailers, law enforcement officials, and educators at DoseofPrevention.org.

In recognition of the importance of combating this trend by teens to look to their medicine cabinets for a high, U.S. Senate leaders again introduced an initiative declaring August as National Medicine Abuse Awareness Month in 2008. CHPA and CADCA, which worked hand in hand to achieve this declaration, commemorated the month by hosting town hall meetings on medicine abuse in Seattle, Washington, and San Antonio, Texas.

CHPA and CADCA also teamed up with the Pharmaceutical Research and Manufacturers of America (PhRMA) on a “newspaper in education” supplement. Working with The Washington Times and the national nonprofit, Newspaper in Education Institute, a 16-page anti-drug supplement was produced for middle-school students, parents, and teachers. The supplement was distributed in early September 2008 to over 250 newspapers nationwide that participate in the NIE program, which has a reach of over 105,855 schools, 380,633 teachers, 14,383,471 students, and a large portion of 100 million newspaper readers. CADCA coalitions also worked to include the supplement in local news outlets and school systems.

One additional CHPA and CADCA collaboration is a follow up to the 2006 CADCA survey of its member coalitions on OTC cough medicine abuse. Using 2006 data as a baseline, the 2008 survey results will provide a measure in levels of change in interest in and awareness of prescription drug and OTC medicine abuse from CADCA members.


Fighting Medicine ABuse on all fronts

the Five Moms campaign was named as a finalist in PRWeek’s “healthcare campaign of the year.”

stopping the Problem Before it starts Peer pressure often plays a role in

many destructive adolescent behaviors,

including the abuse of both OTC and

prescription medicines. One way to

prevent teen medicine abuse is to

educate teens in a peer environment.

Since 2007, CHPA has been involved

with D.A.R.E. America, Abbott

Laboratories, and PhRMA in developing

lesson plans about medicine abuse

for fifth, seventh, and ninth graders.

In the first year, D.A.R.E. curricula reached

500,000 youth in every state and nearly

6,000 D.A.R.E. officers have been trained

in the lessons. The program expanded in

June 2008 with a targeted distribution

of 5,000 lesson plans to both the

National Association of School Nurses

and the American Association of School

Counselors. D.A.R.E. anticipates reaching

700,000 children in elementary and middle

schools during the 2008-2009 school year.

supporting legislationIn line with its educational efforts, the

association continued to work with

congressional champions on Capitol

Hill to advance legislation prohibiting

the sale of cough medicines containing

dextromethorphan to minors and to

ensure that only legitimate entities have

access to the raw, unfinished ingredient.

CHPA also supported age 18 sales

restrictions on OTC medicines containing

dextromethorphan at the federal level.

chPA’s efforts to fight cough medicine abuse have received numerous accolades, including:

• TheCommunityofAnti-DrugCoalitionsof America’s 2008 Champion for Drug Free Kids Award,

• TheW³SilverAwardinthe“BestFamily/Parenting” web site category, and

• The“MakingaDifference”InternetSafetyAward.



changeS t e a m e n g i n e

Introduced in 1772, the steam engine improved

efficiencies and is credited as being the moving

force behind the Industrial Revolution.




Shaping the Future at home and around the world

Because it is a national trade association, CHPA obviously

concentrates on issues that may affect the industry

within the United States. CHPA’s work, however, does

not stop inside the U.S. borders. The association devotes

serious attention to larger, global concerns, recognizing

that what happens in other countries may have an impact

on American consumers.

standing Behind an effective ingredientIn late 2007, FDA continued its review of the active ingredient

phenylephrine, which is commonly used in OTC nasal

decongestant products. The agency’s Nonprescription Drug

Advisory Committee (NDAC) met in December to evaluate

available data on the efficacy of the ingredient in the 10 mg dose.

CHPA participated at the NDAC meeting to present evidence

from multiple clinical trials that shows that 10 mg phenylephrine

is a safe, efficacious, and appropriate OTC dose for the temporary

relief of nasal congestion.

At the conclusion of the meeting, NDAC members voted

almost unanimously that the existing evidence supports the

effectiveness of phenylephrine at the 10 mg dose, but also

noted that the clinical trials are not sufficient by current standards.

In response to NDAC’s recommendations, further research efforts

are being explored by CHPA.

ensuring the Quality of importsQuality problems in imported products from China have raised

strong concerns in the United States this past year. As a result, the

industry has been working closely with the administration, the

International Conference on Harmonization, and the U.S. Congress

on efforts to enhance import safety and quality assurance.


Shaping the Future at home and around the worldCHPA remains engaged with the U.S. Department of Health and Human Services and FDA on implementation of the administration’s November 2007 Action Plan for Import Safety. The plan stresses several industry goals, including placing emphasis on risk-based strategies, building safety and quality into the manufacturing process, using third-party certification, and ensuring

information system interoperability. In addition, CHPA’s work on the regulatory side with the International Conference on Harmonization on the development of quality system design and quality risk-management guidances is a good example of efforts to improve pharmaceutical quality around the world.

On the legislative front, CHPA urged the U.S. Congress to provide FDA with the resources it needs to step up its quality assurance activities. The association also worked with Congress to craft legislation that would establish meaningful consumer safety measures without unduly disrupting the product supply chain.

chPA has been working with the international conference on harmonization to improve pharmaceutical quality around the world.

The switch of medications to over-the-counter status represents a growth driver to the OTC medicine industry and a positive move towards greater consumer access to proven medications.

Following are some of the more notable switches from around the world in 2007 and 2008:

Japan spring 2007

aciclovir topical [cold sores]

usA november 2007

cetirizine [antihistamine, hives relief ]

canada April 2008

diclofenac 1% topical[topical analgesic]

Australia May 2008

pantoprazole[heartburn relief and other symptoms of GERD]

germany July 2008committee recommendation pending approval

calcipotriol[topical mild to moderate psoriasis]

uk August 2008

azithromycin tablets[treatment of con-firmed asymptom-atic Chlamydia]



Focusing on the global PictureOne way that CHPA has achieved a strong international presence is through its participation in the World Self-Medication Industry (WSMI). Since the federation’s founding in 1970, CHPA has been an active and vocal member of this important group that represents manufacturers and distributors of nonprescription medicines on all continents. Late in 2008, CHPA attended the WSMI’s Symposium in Self-Care in Beijing, China, to draw attention to the contribution of self-care to society and provide a special focus on the significant changes China’s drug regulatory system is undergoing.

CHPA also is heavily involved with the International Conference on Harmonization (ICH), which is designed to improve the process for developing and registering new medicines in Europe, Japan, and the United States. The ICH process is helping to bring more people more useful medicines more efficiently and will advance an international approach to ensuring quality. Over the past 12 months, CHPA staff participated as members of ICH expert working groups on quality and safety.

changeP e r s o n A l c o M P u t e r

Introduced in 1977 by Steve Jobs, the personal

computer reduced the size of the device and

enabled average consumers to have box

computers in their homes for the first time. The

growing results of this innovation can be seen in

all sectors of personal and professional life.




Advocating for Positive iMPAct

One of CHPA’s core objectives is to influence policy makers at the federal, state, and local levels. The association works to ensure that public policy goals are met without unduly restricting American consumers’ access to the OTC medicines and nutritional supplement products they want and need.

taking Action on capitol hillCHPA was an aggressive advocate for its members on issues and federal legislation critical to the OTC industry. The association met with congressional staff in many key offices to keep them informed of developments related to the pediatric cough and cold medicines issue, and to reassure staff of the industry’s commitment to consumer safety and advancing pediatric research. The association worked closely with its congressional champions on bills to restrict access to bulk dextromethorphan and prohibit minors from purchasing cough medicines. CHPA also provided extensive input, on behalf of its members, on legislative proposals to impose new quality and documentation requirements on imported drugs.

In addition, the association continued its fight against methamphetamine abuse, including support of legislation that would enhance retailers’ ability to use electronic logbooks to comply with the Combat Methamphetamine Epidemic Act.

CHPA continued its successful efforts with coalition partners to secure the addition of $150 million in funding for the FDA in 2008. Additionally, the president revised the administration’s budget request for fiscal year 2009 to include an extra $375 million for the agency.

Working at the state and local levelOver the past 12 months, CHPA delivered a high overall success rate in protecting consumer access even though the association faced challenges in several states. For example, CHPA effectively advocated preserving nonprescription status for pseudoephedrine products in some states in order to maintain accessibility for families while still limiting criminals’ ability to get these medicines to make the illegal drug, methamphetamine. CHPA also was successful in making sure that confusing state labeling and warning proposals in conflict with federal law were not enacted. In addition, due to growing concerns over drugs in our nation’s water supplies, CHPA stepped up by adopting recommendations for the environmentally sound disposal of medicine and is a supporter of the SMARxT program, a public-private partnership between the U.S. Fish and Wildlife Service, the American Pharmacists Association, and the Pharmaceutical Research and Manufacturers of America. The association also took positions on various Proposition 65 issues in California.

changeB A r c o d e

Allowing for time- and accuracy-efficiencies

over the use of manual inventories, barcodes—

introduced in 1973—enable the speedy passage

of merchandise and other materials through

the supply chain.




CHPA uses a variety of techniques, to keep its members informed about new issues and developments that affect their day-to-day business. By providing quality educational programming and continually updating chpa-info.org and other materials, the association strives to be a valuable resource for all members.

conducting Meetings that Mold the MindCHPA hosted a number of public meetings and conferences last year that were focused on topical issues related to the OTC and nutritional industries. Chief among them were CHPA’s Regulatory & Scientific Conference, held in May, and the association’s Manufacturing Controls Seminar, held in October. In August, CHPA also teamed up with FDA for the annual FDA/industry manufacturing workshop.

In addition to open, public forums, CHPA conducted several members-only events to meet the specific needs and interests of the association’s members. Examples include the association’s Annual Executive Conference, which took place in March; the Government Affairs Conference, which was held in September; and Market Exchange, which also took place in September. Moreover, CHPA’s Business Development Committee hosts a yearly conference for small- to mid-sized CHPA member companies to meet directly with major retailers, conducting an October 2007 conference for members with Wal-Mart and an October 2008 conference for members with four Seattle-area retailers. Additionally, the association’s Logistics Steering Committee sponsors mini-retailer immersions for committee members, such as those with Wal-Mart in October 2007, CVS in January 2008, and Kroger in May 2008.

Making a Beneficial resource even BetterCHPA’s web site, chpa-info.org, is a valuable resource to the thousands of users who visit each year. The site is updated daily to ensure that government officials, healthcare professionals, the media, and consumers have access to the association’s most currentinformation. Most importantly, CHPA makes sure that the site servesthe needs of its members.

In 2008, the association conducted an analysis of the web site to identify ways in which it could be improved. Following the review, several changes were made including the addition of new sections that more accurately reflect the activities of the association. CHPA also expanded the members-only section and reorganized the public section so that all users will be able to navigate even better. Finally, the site was given a cosmetic makeover that improves navigation while highlighting the association’s key initiatives.

Providing opportunities for Future groWth


chPA stAFF officers


linda A. suydam, d.P.A. President

roman g. BlazauskasVice President, Finance & Operations and Treasurer

virginia A. cox, esq.Senior Vice President, Communications & Strategic Initiatives

Andrew c. Fish, esq.Senior Vice President, Legal & Government Affairs, and General Counsel

theodore l. PetersonVice President, Corporate Development

heinz J. schneider, dr. Med.Vice President, Regulatory & Scientific Affairs

david c. spangler, esq.Senior Vice President, Policy & International Affairs

2

5

9

13

17

19

20

A message from CHPA’s president and chair

Treating kids and medicines with care

Fighting medicine abuse on all fronts

Shaping the future at home and around the world

Advocating for positive impact

Providing opportunities for future growth

CHPA staff officers

Contents


chpa-info.org

changeA d v A n c i n g

Relying on science and evidence, utilizing sound judgment, partnering with experts and

community leaders, CHPA has faced a number of challenges and opportunities over the last 12

months. The result is a stronger OTC and nutritional supplement industry. Led by the association’s

committed membership, the consumer healthcare products industry is changing and evolving

and stands ready to take on an even larger role in the healthcare of American consumers.

AdvAncing chAnge 2008 Annual Repor t


chpa-info.org

2008 chpa annual report

Documents

n c i n g c h

otc medicine

chpas president

chpas commitment

chpas members

n g emerriamwebster

orgchangea d v

carefighting medicine